InnoMedica
innomedica.com/en
Group
Worldleaks
Discovered
2025-07-21 13:48 UTC
Est. attack date
2025-05-26
Country
Sector
Agriculture and Food Production
Education
Energy & Utilities
Financial Services
Government & Defense
Healthcare
Hospitality
Manufacturing
Other
Professional Services
Retail & E-Commerce
Technology
Transportation
Description:
[AI generated] InnoMedica is a Swiss-based biopharmaceutical firm focused on the development of tailored treatments for serious conditions such as cancer and neurological disorders. Its primary product, Talidox, is a nanomedical cancer drug that targets only tumor cells. InnoMedica's research is focused towards the technological advancements in medicine to provide more effective treatments.
DNS Records:
The following DNS records were found for the victim's domain.
WHOIS Emails
- abusereportkey-systems.net
- infodomain-contact.org
- abusekey-systems.net
- mailcyon.ch
MX Records
- innomedica-com.mail.protection.outlook.com. Microsoft 365
TXT Records
- keZIW30nQRiRmRuipwyA3kmt5dLtNWlO
- google-site-verification=z0SKrnV1PswokwX-WC96AV7vxxNtC5bIbgPiuwwglpM
- v=spf1 +a +mx +ip4:194.126.200.0/24 +ip4:149.126.0.0/21 include:spf.protection.outlook.com -all
- brevo-code:08f63bc2d80304cd1f8aed28b891641e
Cloud / SaaS Services Detected
Brevo
Leak Screenshot:
Legal Disclaimer: Ransomware.live does not engage in the acquisition, exfiltration, downloading, possession, hosting, access, consultation, redistribution, or disclosure of unlawfully obtained data. This platform indexes only publicly visible information posted by ransomware operators and open web sources without accessing or obtaining the underlying stolen content. The service is provided to support public awareness, legitimate research, and cyber-resilience. No stolen personal or confidential data is collected or distributed via this site.